Suggestions
David Prokop
FDA Funded Ai Researcher - Principal Investigator - Award Winning Ai Product Developer, 32 Patents, Microsoft Researcher, CEO of TruMedicines Ai Hardware Lab at University of Washington
Professional Background
David Prokop is a distinguished Principal Investigator and Lead Research Scientist at the National Institutes of Health's (NIH) Food and Drug Administration (FDA). His groundbreaking work is centered around the innovative development of the TruMedicines Recognition Authentication Cloud Intelligence Software Solutions, specifically the project titled TRACI-4DPS, which addresses pressing challenges in post-marketing drug surveillance. This initiative has been recognized for its potential impact on the healthcare and pharmaceutical landscapes, ensuring that drug products are effectively monitored and evaluated for safety and efficacy post-approval.
In addition to his pivotal role at NIH, David Prokop is also the founder and CEO of TruMedicines. He has previously made significant contributions through his time at Microsoft, where he spent 15 years engaging in research and development across multiple product groups. Notably, he served as a Program Manager for the acclaimed XBOX Kinect, leading the development of its advanced image recognition system. His managerial expertise helped enhance product improvements and implement cost-reduction strategies, demonstrating his commitment to innovation and efficiency.
Education and Achievements
David’s educational background is anchored in a Bachelor of Science degree in Kinematics and Health Studies and Computer Science from the University of Waterloo. His strong foundation in science and technology has propelled him into an impressive career marked by various accolades and patents.
Among his notable achievements, David was recognized as a January 2022 Knowles Corp International Hardware Award winner for his outstanding contributions to hardware development. This award underscores his innovative spirit and dedication to advancing technology within the healthcare arena.
Throughout his illustrious career, David has been awarded an impressive 32 patents across multiple countries, including the USA, Canada, the UK, and China. His patents showcase his exceptional skills in micro-image pattern recognition and include groundbreaking work such as the TeleHealth Medical Device TelePack, which utilizes AI for precise pharmaceutical identification within pill packet dispensers—an advancement that is fully covered by Medicare Advantage Part D plans.
Achievements
David Prokop’s extensive work in research and development, especially within the realms of artificial intelligence and image recognition, has yielded numerous patents, including notable US Patents 8,888,005, 9,477,810, and 9,152,913, along with the Canadian Patent 3,023,359. His patented technologies focus on products, systems, and methods for the unique identification of individual product units, revolutionizing how imaging technology intersects with healthcare.
He has authored the book "Making Pills Talk," which highlights his insights and innovations in the pharmaceutical field. David has founded Prokop Labs, where he engages in the research and development of both software and hardware platforms aimed at enhancing user experience and efficiency.
David's entrepreneurial efforts have led to successful licensing agreements, including a notable partnership with King Leader Tech in Shenzhen, China, to produce a Smart Glass keyboard design. Furthermore, his inventions, such as the Geleez Gel Mousepad Wristrests, recommended by the US Department of Labor OSHA, have garnered attention and success with 11 licensees.
David's litigation success rate, with nine patent enforcement cases settled favorably, speaks to his prowess in intellectual property management and strategic negotiation.
Overall, David Prokop is a visionary leader whose work in AI, image recognition, and pharmaceutical innovations position him as a key player in the future of healthcare technology. He continues to inspire and influence the industry through his ongoing research and development efforts, aiming to create more reliable and efficient health solutions.
